Lemaitre Vascular LMAT
NASDAQ LMAT
$78.74 -0.73 (-0.92%)
As of: Sep 10, 2026 · 3:59 PM EDT

Lemaitre Vascular (LMAT) Current Assets (2010 - 2026)

Lemaitre Vascular's (LMAT) quarterly Current Assets came in at $488.3 million in Q2 2026, up 13.52% year-over-year from $430.1 million in Q2 2025, and up 2.19% quarter-over-quarter from $477.8 million in Q1 2026.

Analysis

Lemaitre Vascular (LMAT) Current Assets (2010 - 2026) Analysis & Trends

Lemaitre Vascular (LMAT) has reported Current Assets for 17 consecutive years, with $488.3 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Current Assets rose 13.52% year-over-year to $488.3 million in Q2 2026; TTM through Jun 2026 was $488.3 million, a 13.52% increase from a year earlier, with the FY2025 full-year figure at $468.2 million, up 16.42% from the prior year.
  • Current Assets was $488.3 million for Q2 2026 at Lemaitre Vascular, up from $477.8 million in the prior quarter.
  • Over five years, Current Assets peaked at $488.3 million in Q2 2026 and troughed at $141.4 million in Q1 2022.
  • A 5-year average of $282.8 million and a median of $207.9 million in 2024 frame the typical range for Current Assets.
  • Across the five-year window, Current Assets jumped 106.68% in 2024 and advanced 13.52% in 2026, its largest moves.
  • Over 5 years, Current Assets stood at $161.7 million in 2022, then advanced by 20.32% to $194.6 million in 2023, then surged by 106.68% to $402.2 million in 2024, then increased by 16.42% to $468.2 million in 2025, then advanced by 4.29% to $488.3 million in 2026.
  • The last three Current Assets figures came in at $488.3 million (Q2 2026), $477.8 million (Q1 2026), and $468.2 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Assets (Qtr)
1 Abbott Laboratories 179.79 Bn 174.18 Bn 7.27 Bn 24.52 Bn
2 Intuitive Surgical 127.69 Bn 122.47 Bn 1.96 Bn 9.54 Bn
3 Medtronic 117.23 Bn 108.41 Bn 6.34 Bn 24.39 Bn
4 Stryker 103.55 Bn 100.07 Bn 4.50 Bn 14.42 Bn
5 Boston Scientific 63.24 Bn 62.70 Bn 3.85 Bn 7.97 Bn
6 Edwards Lifesciences 49.97 Bn 45.72 Bn 1.35 Bn 6.82 Bn
7 Alcon 32.83 Bn 31.37 Bn 1.68 Bn 6.62 Bn
8 Dexcom 32.30 Bn 30.35 Bn 830.00 Mn 4.09 Bn
9 Steris 20.73 Bn 20.25 Bn 684.20 Mn 2.45 Bn
10 Lemaitre Vascular 1.80 Bn 1.43 Bn 50.76 Mn 488.30 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 488.30 Mn
Mar 31, 2026 477.82 Mn
Dec 31, 2025 468.23 Mn
Sep 30, 2025 452.03 Mn
Jun 30, 2025 430.13 Mn
Mar 31, 2025 408.11 Mn
Dec 31, 2024 402.19 Mn
Sep 30, 2024 227.12 Mn
Jun 30, 2024 212.81 Mn
Mar 31, 2024 202.96 Mn
Dec 31, 2023 194.60 Mn
Sep 30, 2023 182.18 Mn
Jun 30, 2023 174.49 Mn
Mar 31, 2023 164.77 Mn
Dec 31, 2022 161.73 Mn
Sep 30, 2022 153.14 Mn
Jun 30, 2022 148.49 Mn
Mar 31, 2022 141.41 Mn
Dec 31, 2021 139.88 Mn
Sep 30, 2021 134.02 Mn